Total Visits

Views
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis692

Total Visits Per Month

August 2015September 2015October 2015November 2015December 2015January 2016February 2016
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis161631133

File Visits

Views
cancers-03-01329.pdf639
license.txt63
sword-2012-02-16.original2

Top country views

Views
United States339
China85
Ireland59
Germany26
Russia16
Japan14
Netherlands14
United Kingdom11
France8
Belarus7

Top cities views

Views
Cleveland66
Mountain View56
Woodbridge42
Oranmore39
Sunnyvale35
Beijing30
Seattle11
Gaillimh9
Kiez8
Leipzig8